Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 08, 2019 11:24 ET | Source: AstraZeneca

Lung Ambition Alliance diluncurkan dengan tujuan untuk menggandakan kelangsungan hidup selama lima tahun dalam kanker paru-paru pada tahun 2025

LONDON, July 08, 2019 (GLOBE NEWSWIRE) -- Hari ini, International Association for the Study of Lung Cancer (IASLC), Guardant Health, Global Lung Cancer Coalition (GLCC), dan AstraZeneca mengumumkan...
July 08, 2019 02:00 ET | Source: AstraZeneca

Lung Ambition Alliance launches with goal to double five-year survival in lung cancer by 2025

LONDON, July 08, 2019 (GLOBE NEWSWIRE) -- Today, the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca...
April 16, 2018 17:05 ET | Source: AstraZeneca

AstraZeneca Presents Imfinzi (durvalumab) Plus tremelimumab Combination Data at AACR Annual Meeting

Phase Ib Study 006 long-term follow-up shows clinical activity in PD-L1 ≥25% and <25% groups in 2nd-line non-small cell lung cancer Phase I Study 10 data shows clinical activity with combination...
March 22, 2004 11:12 ET | Source: AstraZeneca

AstraZeneca Does Not Recommend or Endorse Unsolicited 'Mini-Tender' Offer

London, UK, March 22, 2004 (PRIMEZONE) -- AstraZeneca Does Not Recommend or Endorse Unsolicited "Mini-Tender" Offer AstraZeneca PLC announced today that it has...